HTLV-1 infection to hematopoietic stem cells
Project/Area Number |
17K19610
|
Research Category |
Grant-in-Aid for Challenging Research (Exploratory)
|
Allocation Type | Multi-year Fund |
Research Field |
Tumor biology and related fields
|
Research Institution | Kumamoto University |
Principal Investigator |
Matsuoka Masao 熊本大学, 大学院生命科学研究部(医), 教授 (10244138)
|
Co-Investigator(Kenkyū-buntansha) |
安永 純一朗 京都大学, ウイルス・再生医科学研究所, 講師 (40362404)
|
Project Period (FY) |
2017-06-30 – 2020-03-31
|
Project Status |
Completed (Fiscal Year 2019)
|
Budget Amount *help |
¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000)
Fiscal Year 2018: ¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2017: ¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
|
Keywords | HTLV-1 / Tax / 血液幹細胞 / 成人T細胞白血病 / HTLV-1関連脊髄症 / ヒトT細胞白血病ウイルス1型 / レトロウイルス / 潜伏感染 / 樹状細胞 / リザーバー |
Outline of Final Research Achievements |
HTLV-1 infects mainly CD4+ T cells in vivo. However, its receptor is glucose transporter 1 (GLUT-1). We found the same integration sites in the different hematopoietic cells, indicating that HTLV-1 infects hematopoietic stem cells. The proportion of infected CD4+ T cells with identical integration sites is 16-35%. More than half of Infected neutrophils exist over one year. Presence of HTLV-1 infected hematopoietic stem cells is possibly the basis for leukemogenesis by HTLV-1.
|
Academic Significance and Societal Importance of the Research Achievements |
HTLV-1の血液幹細胞への感染は否定されてきたが、今回の研究はこれを証明し、HTLV-1の感染拡大様式に新たな知見をもたらした。我々の研究を発表した後にATL患者で同じHTLV-1プロウイルス組み込み部位を有しているが異なるT細胞受容体再構成を有する症例が複数報告された。HTLV-1が感染した未熟な細胞が白血病となっていることを示しており、我々の研究はATLの発症機構に新たな展開をもたらす知見である。
|
Report
(4 results)
Research Products
(30 results)
-
-
-
-
-
-
-
-
-
[Journal Article] afety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell.2018
Author(s)
Inoue, Y., Endo, S., Matsuno, N., Kikukawa, Y., Shichijo, T., Koga, K., Takai, A., Iwanaga, K., Nishimura, N., Fuji, S., Fukuda, T., Nosaka, K., and Matsuoka, M.
-
Journal Title
Bone Marrow Transplant.
Volume: 54
Issue: 2
Pages: 338-342
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy.2018
Author(s)
Sato T, Coler-Reilly ALG, Yagishita N, Araya N, Inoue E, Furuta R, Watanabe T, Uchimaru K, Matsuoka M, Matsumoto N, Hasegawa Y, Yamano Y.
-
Journal Title
N Engl J Med.
Volume: 378(6)
Issue: 6
Pages: 529-538
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] HBZ downregulates miR-455, a tumor suppressor microRNA in ATL2017
Author(s)
Ma, G., Yasunaga, JI., Miura, M., Matsumoto, T., Matsuoka, M.
Organizer
第4回日本HTLV-1学会学術集会
Related Report
-
-
-